Gyre Therapeutics Inc (GYRE)

SG&A Expense Growth

1.24%

Quarterly · Period ending:

GYRE logo

GYRE SG&A Expense Growth

Latest reported1.24%
GYRE Quarterly SG&A Growth (QoQ) (0.00% → 1.24%)
High-resolution chart · PNG

GYRE sg&a expense growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Gyre Therapeutics Inc SG&A Expense Growth — Quarterly
Period endingSG&A Expense Growth
1.2409%
-30.0193%
55.3265%
-12.5712%
42.2639%
-29.2294%
27.3827%
-1.7715%
11.9072%
-39.8922%
75.7971%
-23.4652%
35.8654%
-34.8959%
-1.818%
490.4111%
-23.0276%
19.9328%
-14.4794%
7.7689%
-16.5188%
26.3011%
11.7923%
-12.3084%
18.4232%
16.8038%
-3.3048%
-0.0612%
-11.31%
7.0247%
24.3682%
-14.1085%
10.6726%
12.6837%
8.1556%
-9.9096%
11.4658%
9.2703%
-10.1443%
6.7342%
-5.1357%
-20.8788%
20.6938%
-8.7004%
109.375%
22.0465%
26.6196%
-30.4098%
-55.8451%
4.3823%
-6.5984%
-6.592%
-13.0659%
12.4356%
27.6316%
-46.9806%
49.4137%
1.622%
6.2984%
-9.1723%
-1.4488%
34.3063%
15.2047%
13.1202%
-0.4391%
-50.6233%
126.6585%
18.228%
-6.3265%
-3.0916%
8.5746%
-26.2317%
11.9926%
-20.4664%
10.761%
-26.9648%
96.418%
-32.2826%
61.8487%
-8.2762%
13.9817%
-57.8106%
138.916%
-7.5572%
3.6673%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.